Abstract:Abstract Background Carbon nanotubes (CNTs) usage has rapidly increased in the last few decades due to their unique properties, exploited in various industrial and commercial products. Certain types of CNTs cause adverse health effects, including chronic inflammation and fibrosis. Despite the large number of in vitro and in vivo studies evaluating these effects, many important questions remain unanswered due to a lack of mechanistic understanding of how CNTs induce cellular stress responses. In order to predict CNT toxicity, it is important to understand which transcriptional programs are specifically activated in response to CNTs, and what similarities and differences exist in relation to other toxic inducers exerting similar adverse effects. Results A systems biology approach was applied to reveal complex interactions at the molecular level in mouse lung tissue in response to different fibrosis inducers: two types of multi-walled CNTs, NM-401 and NRCWE-26, and bleomycin (BLM). Based on mRNA gene expression profiles, we inferred gene regulatory networks (GRNs) to capture functional hierarchical regulatory structures between genes and their regulators. We found that activities of the transcription factors (TFs) Myc, Arid5a and Mxd1 were associated with the regulation of cytokine transcription in response to CNTs, while in response to BLM treatment, Myc was associated with p53 signaling. TF Litaf was identified as the essential regulator for noncanonical signaling of TLR2/4 driven by CNTs. Despite the different nature of the lung injury caused by CNTs and BLM, we identified common stress response modules, that included DNA damage (TFs: E2f8, E2f1, Foxm1) , M1/M2 macrophage polarization (TF: Mafb), Interferon response (TFs: Irf7, Stat2 and Irf9) for all agents. Conclusions These results suggest that the reconstruction and analysis of TF-centric gene interaction networks can reveal key targets and regulators of cellular stress responses to toxic agents.

Lanthanides-Induced Cellular Signal Transduction: Implications in Pathogenesis of Fibrosis

Safety Issues of Lanthanide-Based Compounds as Diagnostic and Therapeutic Agents as Viewed from Cellular Inorganic Chemistry

Recent progress in therapeutic and diagnostic applications of lanthanides.

Insights into the effects of lanthanides on mammalian systems and potential applications

Lanthanides—the Future Drugs?

The Neural Toxicity of Lanthanides: an Update and Interpretations

Biotransformation of soluble-insoluble lanthanum species and its induced NLRP3 inflammasome activation and chronic fibrosis

Molecular Mechanism of Gd@C82(OH)22 Increasing Collagen Expression: Implication for Encaging Tumor

Intracellular Adenosine Triphosphate Deprivation Through Lanthanide-Doped Nanoparticles.

Progress of Signaling Pathways, Stress Pathways and Epigenetics in the Pathogenesis of Skeletal Fluorosis

Electron microscopy evidence of gadolinium toxicity being mediated through cytoplasmic membrane dysregulation

Organ Histopathological Changes and Its Function Damage in Mice Following Long-Term Exposure to Lanthanides Chloride.

Gadolinium-promoted Precipitation of Calcium Phosphate is Associated with Profibrotic Activation of RAW 264.7 Macrophages

Pulmonary Surfactant Homeostasis Dysfunction Mediates Multiwalled Carbon Nanotubes Induced Lung Fibrosis via Elevating Surface Tension

Transcriptional regulatory mechanisms of fibrosis development in mouse lung tissue exposed to carbon nanotubes

Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes

Impaired Mitochondrial Function and Oxidative Stress in Rat Cortical Neurons: Implications for Gadolinium-Induced Neurotoxicity

The reactions between lanthanons and metallothionein

Epithelium-derived exosomes promote silica nanoparticles-induced pulmonary fibroblast activation and collagen deposition via modulating fibrotic signaling pathways and their epigenetic regulations

Lanthanide Hydroxide Nanoparticles Induce Angiogenesis via ROS-Sensitive Signaling

Proangiogenic effect and underlying mechanism of holmium oxide nanoparticles: a new biomaterial for tissue engineering